학술논문

A Multicenter Phase-Ib/II Study of Ruxolitinib/Pomalidomide Combination Therapy in Patients with Primary and Secondary Myelofibrosis: Safety Data from the Mpnsg-0212 Trial (NCT01644110)
Document Type
Abstract
Source
In Blood 6 December 2014 124(21):3161-3161
Subject
Language
ISSN
0006-4971